Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070484 · ClinicalTrials.gov registry record · NA
Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease
A NA study, sponsored by OhioHealth.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02070484 is a NA study that was terminated before completion, run by OhioHealth. The registered enrollment target is 6 participants.
The verdict
NCT02070484, a NA study, was terminated before completion, sponsored by OhioHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect and safety of NuCel to DBX on patients undergoing posteriolateral lumbar spinal fusions for degenerative disc disease.
Interventions
- BIOLOGICAL NuCel
- BIOLOGICAL Demineralized Bone Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02070484
The ClinicalTrials.gov registry entry for NCT02070484 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OhioHealth, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NuCel is the first listed.
NCT02070484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02070484 about?
NCT02070484 is a clinical study titled "Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease". The purpose of this study is to compare the effect and safety of NuCel to DBX on patients undergoing posteriolateral lumbar spinal fusions for degenerative disc disease.
What is the current status of trial NCT02070484?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2014-02. Estimated completion is 2017-03-24.
What interventions are being tested in trial NCT02070484?
The interventions under investigation include: NuCel (BIOLOGICAL), Demineralized Bone Matrix (BIOLOGICAL).
Who is sponsoring clinical trial NCT02070484?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.